Skip to main content
BMC Medical Ethics logoLink to BMC Medical Ethics
. 2022 Nov 21;23:117. doi: 10.1186/s12910-022-00849-x

Electronic informed consent criteria for research ethics review: a scoping review

Mohd Yusmiaidil Putera Mohd Yusof 1,2,, Chin Hai Teo 3,4, Chirk Jenn Ng 4,5
PMCID: PMC9682656  PMID: 36414962

Abstract

Background

The research shows a growing trend in using an electronic platform to supplement or replace traditional paper-based informed consent processes. Instead of the traditionally written informed consent document, electronic informed consent (eConsent) may be used to assess the research subject’s comprehension of the information presented. By doing so, respect for persons as one of the research ethical principles can be upheld. Furthermore, these electronic methods may reduce potential airborne infection exposures, particularly during the pandemic, thereby adhering to the beneficence and nonmaleficence principle. This scoping review aims to identify the ethics related criteria that have been included in electronic informed consent processes and to synthesize and map these criteria to research ethics principles, in order to identify the gaps, if any, in current electronic informed consent processes.

Methods

The search was performed based on internet search and three main databases: PubMed, SCOPUS and EBSCO. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation guideline was used to report this work.

Results

Of 34 studies that met the inclusion criteria, 242 essential original constructs were collated, and 7 concepts were derived. Digital content showed the highest percentage of collated original constructs (27%, n = 65) followed by accessibility (24%, n = 56), comprehension engagement (18%, n = 43), autonomy (14%, n = 34), confidentiality (11%, n = 25), language (5%, n = 13), and parental consent (1%, n = 2). Twenty-five new items were synthesized for eConsent criteria which may provide guidance for ethical review of research involving eConsent.

Conclusion

The current study adds significant value to the corpus of knowledge in research ethics by providing ethical criteria on electronic informed consent based on evidence-based data. The new synthesized items in the criteria can be readily used as an initial guide by the IRB/REC members during a review process on electronic informed consent and useful to the future preparation of a checklist.

Supplementary Information

The online version contains supplementary material available at 10.1186/s12910-022-00849-x.

Keywords: Electronic informed consent, Institutional review board, Research ethics committee, Autonomy

Background

Informed consent acts as a safeguard for the potential research participants to be informed about the nature of the research trials they are requested to participate [1]. Potential research participants need to be informed about the research procedures; the potential risks, possible benefits; autonomy or right to decline to participate or withdraw without being penalized following agreement to participate; assurance on confidentiality issues; reimbursement, compensation and incentives for participating; and the contact information of the researchers should the participant have any concerns about the study [2]. This information is generally disclosed through a participant information sheet coupled with the participant's written informed consent document before participating in the study.

In several investigations to assess comprehension and recall of informed consent and related legal informational documents, participants were reported to not reading or only skimming the material, and recall findings support these reports [3, 4]. Entrusting the researcher, not having time to read the document, and having had the document verbally explained are among the common motives for not reading these documents [5]. In addition, participants’ comprehension of and recall for the information is affected by readability and vocabulary of the document based on their age, education, and cognitive and mental status even when they carefully read informed consent [6]. Not reading or not understanding (or both) informed consent documents may lead to severe consequences. Stanley and Guido found that participants in some medical research studies did not even realize they were participating in research [7].

The Belmont Report categorizes three basic ethical principles for conducting research that involve human participants and expounds guidelines to assure these principles are to be abided throughout the research process [8]. The basic ethical principles include respect for persons, beneficence, and justice to the human research participants. In general, the use of electronic informed consent has been associated with increased comprehension among the research participants and hence, enhancing the beneficence [9, 10]. The principles highlighted in this report are pivotal and will be used as principal guidance in this study.

With the growing use of digital health tools, electronic informed consent (eConsent) has become a crucial element in health research and standard clinical care, especially during and post- Covid-19 pandemic [11, 12]. eConsent enables sites to continue to consent and re-consent patients in clinical trials during the time of self-isolation [13]. Not only does it allow research participants to consent in the comfort of their home, but it also provides quantitative and qualitative data that is not readily available through traditional paper consent forms [11]. According to Chen et al., 2020, there was no unified approach or guideline for replacing paper-based consent with eConsent.

Despite an increasing number of studies utilizing electronic informed consent, the reviewing process of this type of informed consent across the ethical committee may be inconsistent and incomprehensive especially when the committee is facing different electronic media such as graphics, audio, video, podcasts, and websites [14, 15]. As the electronic informed consent is different from paper-based informed consent, problems may arise that could impair the participant's autonomy to make decisions. The objectives of this study are twofold: (1) to identify the criteria in ethical conduct of electronic informed consent taking; and (2) to synthesize and map these criteria to research ethics principles, in order to identify the gaps, if any, in current electronic informed consent processes.

Methodology

The main methodological approach for this research is a scoping review. Generally, scoping reviews aim to map literature on a particular topic and explore the underpinnings of a research area, as well as identify and clarify the key concepts, theories, sources of evidence and gaps in the research [16].

In this first phase of the study, scoping review was performed according to guidelines set forth by the Joanna Briggs Institute [17] and the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) [18] for the conduct and reporting of scoping review, respectively. Methodological framework starting from identifying research questions, identifying relevant studies, study selection, charting the data, collating, summarizing, and reporting of the results was performed based on the flowchart for scoping review process as depicted in Fig. 1 [16].

Fig. 1.

Fig. 1

Scoping review flowchart

Inclusion criteria for the selected articles within the current scoping review included publication time period from 1998 to 2021, English language and focusing on eConsent within the scope of health research/trials. The reason for the chosen time frame was based on the preliminary search for eConsent trend on PubMed. Studies focusing on eConsent within the scope of clinical practice and local regulations, or law were excluded from the review. This scoping review's research question is formulated based on Population, Concept, and Context (PCC) framework; Population: Any population, Concept: Electronic informed consent and Context: IRB/IEC review and oversight.

Identification of relevant studies

A comprehensive search for relevant articles was performed using three databases that includes PubMed, SCOPUS and EBSCO. Articles from commentaries, opinion pieces, blogs and online materials were also included within this scoping review. Also, at the outset of the study, local experts from the research ethics committee were consulted to formulate a preliminary proposition on the review of the electronic informed consent within their practice. The selection of the local experts was based on their experience in the research ethics committee and availability. In addition, reference mining was performed following a full text article collection. Boolean logic using ‘OR’, ‘AND’, and ‘NOT’ and MeSH terms was utilized to enhance the search (Additional file 1: Appendix I for search strategy). A single reviewer (MYPMY) gathered data from all fully eligible studies and organized it in a data extraction excel form according to the predetermined variable headings. Another reviewer (TCH) went over the data obtained separately to ensure consistency. Any conflicts that arose were handled by NCJ as the third reviewer.

Study selection

Under study selection, title and abstract screening, followed by full-text screening using pre-defined inclusion and exclusion criteria, was performed. All related duplicates were removed, and reference was managed using EndNote® software.

Charting the evidence

The evidence’s charting was gathered using a pre-defined, standardized charting form (Additional file 2: Appendix II) using Windows’ Microsoft Excel 2019 16.0.6742.2048. The studies were charted according to geographic area, article type, study design and population. These were reported using descriptive statistics. 

Data synthesis

The constructs in this review are defined as the domains that are used to inform the ethical conduct and review of electronic informed consent. The ethical constructs were identified by screening and transcribing the texts of the primary articles verbatim. Prior to constructs synthesis, all items were labelled according to specific item number obtained from each primary study/resource. For constructs synthesis, all of the extracted verbatim constructs were first sorted according to common themes. The themes were then named to form the concepts for the conduct of electronic informed consent. The constructs within each concept were also synthesised through a process of rewording and merging to remove duplicative constructs. The synthesis was performed by a single review author (MYPMY) and consensus was obtained via discussions with the other two review authors (TCH and NCJ). The final framework was presented with the newly synthesized constructs under each concept.

Results

This scoping review identified a total of 1745 potentially eligible articles that were published between January 1998 to April 2021 (Fig. 2). The results were generated across three databases, namely PubMed (n = 719), SCOPUS (n = 71), and EBSCO (n = 1,087). Additional records were identified through other sources such as internet search (n = 8), and reference mining (n = 3). Out of these, 1243 articles were identified and removed due to duplication. The titles of the remaining 502 articles were screened. Following the next phase of the screening process, 391 articles were further eliminated, after title screening (n = 328) and abstract screening (n = 63). The full texts of a total of 111 papers were further reviewed and compared to fit the inclusion and exclusion criteria model.

Fig. 2.

Fig. 2

Selection process of the studies included based on PRISMA-ScR Flow Diagram

After the full text screening process is completed, a total of 77 articles were excluded with the reasons as listed: no full text (n = 5), language other than English (n = 7), does not address electronic informed consent covering the ethical or legal or regulatory or user interface perspectives (n = 65). The search strategy was done following the PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation guideline [17], as described in the methodology, and as presented in Fig. 2. A total of 34 articles that fitted the inclusion criteria were included in the qualitative synthesis.

Characteristics of the selected articles and the online materials were tabulated in Table 1. The majority of the articles originated from North America (65%, n = 22) followed by Europe (32%, n = 11) and Asia (3%, n = 1). Of these, twelve articles used randomised controlled trials while thirteen articles adopted methodical/framework analysis for their study design with percentage of 35% and 38%, respectively. Interviews/surveys and scoping/systematic reviews were among the study designs performed in primary studies. Overall, the area of the studies displayed a wide extent of topics ranging from electronic health records (36%, n = 13) to cybersecurity (3%, n = 1). Most documents were from academic researchers.

Table 1.

Characteristics of articles and online materials meeting the inclusion criteria

Domain of interest N = 34 (%)
Geographic area
North America, n (%) 22 (65)
Europe 11 (32)
Asia 1 (3)
Article type
Original research 18 (50)
Perspective 12 (39)
Review 4 (11)
Study design
Randomised controlled trial 12 (35)
Methodical/framework analysis 13 (38)
Interviews/surveys 6 (18)
Scoping/systematic review 3 (9)
Area of study
Electronic health records 13 (36)
Surgery 4 (11)
HPV and HIV research 3 (8)
Stakeholder groups 3 (8)
App development 6 (22)
Patients underrepresented in research 2 (6)
Cybersecurity 1 (3)
Regulations and guidelines 2 (6)

Of the 34 eligible articles, 242 essential original constructs were collated. All original constructs were tabulated according to the authors and their specific title (Additional file 3: Appendix III). Original constructs within the context of this study are defined as the underlying ethical themes in conducting and reviewing the electronic informed consent. 32 articles were academic resources while 2 articles were internet-based (United States Food and Drug Administration and REDCap).

Of the 242 original constructs, four were deleted (Items 34.5, 34.6, 34.7, 34.8). The four items were deleted due to specific requirements from local regulations and laws. All four deleted items were from the same study [19]. The remaining 238 items were modified through a process of rewording and merging. Subsequently, seven concepts for the conduct of electronic informed consent were established: accessibility, autonomy, engagement for comprehension, confidentiality, digital content, language, and parental consent. In general, 65 items were categorized under the concepts of digital content followed with accessibility (n = 55), engagement for comprehension (n = 42), autonomy (n = 33), confidentiality (n = 24), language (n = 12), and parental consent (n = 2). The summarized descriptions were further synthesized resulting in the development of 25 newly synthesized constructs (Table 2).

Table 2.

New synthesized constructs for electronic informed consent

Engagement for comprehension Digital content Accessibility Parental consent Language Confidentiality Autonomy
1. Undertaking the consent process before the day of intervention 1. Establish digital technology for participants to track the use of their biological sample over time 1. Identify the demographics and needs of the participants 1. Give opportunity to gather information from parents/LAR 1. Simplify the language 1. Use encryption for data in transit 1. Participant is always able to control and restrict the access to the shared record
2. Support social annotation whereby participants can see each other comments for discussions 2. Use validated electronic signature 2. Establish tracking mechanism for separate consents 2. Use multiple language 2. Provide secured and proper authentication 2. Use only explicit consent
3. Provide interactive personnel to optimize comprehension and trust 3. Establish digital storing biometric information on cloud storage 3. Integrate research consent data with electronic health record 3. Needs to be legally binding 3. Participant is always able to control their own pace during consent process
4. Fulfil general requirements and elements of informed consent 4. Support interactive digital components such as online quiz, graphical media and audio-visual aid 4. Participants receive a copy of the completed consent form 4. Provide options to discuss in private 4. Allow participant to amend their consent
5. Support information technology infrastructure 5. Allow IRB oversight and amendment

Digital content showed the highest percentage of collated original constructs (27%, 65/238) followed with comprehension engagement (18%, 43/238) in concept distribution (Fig. 3). Autonomy and confidentiality exhibited 14% (34/238) and 11% (25/238), respectively. The least percentage for electronic informed consent constructs described in literature were language (5%, 13/238) and parental consent (1%, 2/238).

Fig. 3.

Fig. 3

Concept distribution in electronic informed consent

Discussion

Generally, the electronic informed consent has fulfilled the general elements of informed consent. However, based on our understanding of the literature, it appears that the criteria are different from traditional pen-and-paper informed consent. As more healthcare research moves to an electronic platform, it is more important than ever to assess the criteria for conducting electronic informed consent taking processes.

The primary papers and internet materials identified in the search showed a skewed tendency to North America. Considering the broad applicability of electronic informed consent following the COVID-19 pandemic, it is postulated that more research will be performed in this topic. Nevertheless, it is also interesting to note that since the current scoping review is focusing on electronic informed consent within the context of healthcare research ethics, it may partly explain the demographic skewness. Significant number of papers were omitted during the earlier phase of the review search that were primarily performed under the contexts of clinical practice and clinical ethics.

Four original items were deleted due to their specific descriptions being based on local regulations. As this study was undertaken with the assumption that general requirements for informed consent must be free from the influences of local regulations and laws, these items were removed. Code of Federal Regulations (CFR) 11 (Electronic Records; Electronic Signatures) was the specific local regulations for all these four items. As this regulation only applies to the USA, the justification for removal is met. It is interesting to note that all these items stemmed from a single study [19, 20].

The primary reviewer and research team members met frequently to improve the reliability and quality of the study selection in this scoping review. Differences and disagreements were laid out on the table, and a consensus was established. It is worth noting that the present scoping study did not use the same quality rating tools as the systematic review, such as CASP or Cochrane RoB 2 [17]. Therefore, although the use of such a tool is not generally a practice in conducting and reporting scoping review, the lack of it may reflect a limitation in this study. In addition, seven key concepts that hold twenty-five new synthesized items for the identified criteria of electronic informed consent have been framed within this study.

Accessibility

Accessibility is the top two important concepts formulated for the conduct of informed consent in this study. Chen and his team through REDCap-based workflow for electronic informed consent had outlined most of their frameworks of electronic informed consent on accessibility [19]. In fact, with thirty-six original items on their study alone, they have become the group’s largest contributor. However, as their work on REDCap was based on specific federal guidance in the United States of America (USA), some of the items were omitted. In addition, another Switzerland-based study using Fast Healthcare Interoperability Resources (FHIR) on the conduct of electronic informed consent taking suggested implementing a custom label reader to retrieve participant data needed for the consent document, such as name, date of birth and participant special identification number [21]. It is important to note that both REDCap and FHIR works were developed according to local regulatory settings and the applicability of such systems may require validations prior to broad implementations.

As far as the accessibility goes, the involvement of IRB/REC is important in reviewing the electronic informed conduct. The oversight and review of the conventional informed consent is already well established in almost all local IRB/REC settings [22]. Therefore, the access to institutional review board purview was established as part of the twenty-five preliminary checklist items in this study.

Autonomy

The mechanism to allow participants to amend their consent and access the shared record and issues on timing and how participants will be able to control their pace during the process of electronic informed consent were considered in upholding the autonomy to research participants. The use of explicit consent as opposed to implicit and opt-out consent were also key issues in this preliminary checklist item. Consent can be changed in a variety of ways, from protocol updates and changes to withdrawal to reflect the autonomy.

A dynamic consent model was presented mainly in biobank studies, which allows for personalization and flexibility, such as allowing a biobank member to update their broad consent based on new research activity [23]. Dynamic electronic informed consent is defined as using technology to maintain ongoing engagement with participants in order to retain their consent choices [24]. Interestingly, several studies have stated that participants may only desire to consent to providing restricted data to for-profit businesses [2527]. There are a variety of technical techniques to tracking this data electronically, ranging from blockchain [28] to other models [21]. Two studies described reputable third-party entities that would keep the data safe and control who had access to it [28, 29].

The processes for allowing consent revisions at various levels of attainment by research participants need to be reviewed by the IRB/REC. Therefore, we recommend that researchers either provide a screen capture of the electronic informed consent procedures to describe the mechanism in place or utilise the system that has already been implemented by institutions.

Engagement for comprehension

Interactions and communications between researchers and participants are one of the most important factors for measuring engagement for comprehension. This in turn has the potential to foster the trust among the study participants. According to Chen et al. 2020, regardless of the form of consent, numerous studies have advocated that in-person interactions or other forms of communications with researchers remain a part of the electronic informed consent process, to ensure participants' understanding of consent information and to foster trust, especially for more complex and risky studies. Interactive personnel to optimize comprehension and trust was an essential part of developing the checklist. Large number of items were collated based on this factor. Amongst other original items/construct to depict this issue includes:

“Questions should be answered via in person discussions or combination of electronic messaging, telephone calls, video conferencing, or live chat with remotely located investigator or study personnel” [19].

“Interactive, multiple-choice questions were inserted at relevant points in the slideshow to emphasize critical concepts” [30].

“In-person interactions or other forms of communications with researchers remain a part of the eConsent process, to ensure participants’ understanding of consent information and to foster trust, particularly for more complex and riskier studies” [31].

In Item 14.3 to Item 15.8, social annotation was highlighted, and the original items were merged as ‘Support social annotation whereby participants can see each other’s comments for discussions.’ The importance of comprehension and understanding was significantly considered whereby the discussion on undertaking the consent process prior to the day of intervention was merely noted.

Some studies revealed that when electronic informed consent included interactive components, quizzes, personalized material, graphical media, and annotations, participants (including minors) had a greater knowledge of the information presented to them [30, 3235]. In one scenario, participants with and without mental illness have the same degree of understanding, but in participants with schizophrenia, a web-aided multimedia consent may assist understanding and deliver better satisfaction [36].

In a traditional pen-and-paper informed consent, engagement for comprehension is usually not a major issue because the researcher would be present to explain everything to the research participants. However, in electronic informed consent, as most explanations will be provided by a third party, such as an animated character or avatar, IRB/REC may require that this factor be considered, as well as methods to prevent communication breakdown between research participants and researchers.

Confidentiality

Hall and his team suggested a deduplication protocol to remove duplicate or artificial survey attempts. Their study also highlighted the potential fraudulent responses from artificial hacking or bot programs possibly aimed at getting the monetary incentive and the importance to establish indicators for that [37]. Following that, initiatives have been set up to put measures in place including Completely Automated Public Turing test to tell Computers and Humans Apart (CAPTCHA) codes and verification of email addresses submitted for incentives [3739]. In a systematic review on the implementation of electronic informed consent in healthcare research and stakeholder’s perspectives, most participants in the study emphasized the necessity of trusting the legitimacy of electronic informed consent when sharing health information and agreeing to participate in the study [40]. Researchers believe that a secure platform will facilitate the sharing of files, which is a vital aspect in biomedical research. Individual user identities and passwords were required to access the electronic informed consent platform that Chhin and his colleagues built [41]. Furthermore, researchers stressed the importance of providing sufficient privacy information to potential research participants [42].

Confidentiality measures must be implemented in order to acquire the trust of study participants. This aspect requires regular review and control by the IRB/REC. Although researchers are expected to take proactive measures to address this problem, and ultimately performed by the data protection personnel at the institution, the IRB/REC must assure that the mechanisms to check for data protection process such as updated anti-virus and anti-malware software, as well as the use of e-consent software/platforms with embedded end-to-end encryption protection. The ethical application document must also include strategies for improved password security when using online platforms, as well as data storage processes that are transparent (particularly if they are asked to complete e-consent on portable devices, which are not their own). Using iconography (such as a padlock image) to indicate data security safeguards might also be reassuring to worried participants.

Digital content

Digital content is another key to the implementation of electronic informed consent. Based on the several models for electronic informed consent, the use of an avatar to substitute human personnel is a plus feature for the electronic platform [43]. This feature may engage young and adolescent participants in the most significant way and therefore, it is envisaged to be highly interactive. However, the technology may require expertise and thus, may incur some costs.

The use of animations and avatars have been proposed by several studies [4345]. To establish confidence, the avatar should appear as medical staff with lab coats and stethoscopes [43]. However, most studies agreed that avatars should not replace interactions with study staff [43, 46].

Electronic signatures for consent in the USA must comply with 21 CFR 11(c), a federal requirement that states that an electronic signature must be unique to one person and that organizations must verify that person’s identification. Researchers in Europe are subjected to comparable requirements [47]. Some IRBs were unsure whether electronic signatures were valid, which regulations would apply, and how the electronic signatures would be preserved, according to a study [48]. Therefore, in our opinion, the research teams will need to be requested to confirm whether an electronic informed consent method will be employed, and if so, whether the technology is capable of providing a verified signature while also meeting all legal criteria. A description of the recruitment and consenting approach that is consistent with how the electronic informed consent is provided will also be required. In addition, the IRB/REC will need to assess how the electronic signature is created, whether the signature can be proven to be valid, and how the research team plans to give a version of the permission form to the potential subject for review and retention when they review the study.

Secure authentication and the use of digital signatures were the inevitable component of electronic informed consent. According to Chen et al. 2020, the use of USign, a signature verification method that can integrate with existing electronic informed consent systems and provide a new authentication token should be seriously considered [31]. Electronic signature, however, is also discussed within digital consent concept as its use was separately conferred according to its contexts.

Language

When it comes to language, most original items were in accord with each other on how the language should be presented in electronic informed consent [4951]. Appropriateness, simplicity and concise are the adjectives used to simplify the language. It is interesting to note that although this requirement is included as one of the elements in general informed consent, the electronic informed consent has more flexibility in terms of freedom to add more language of interest. As all options are within click in electronic informed consent, the potential participants may proceed with their language of choice and thus, the principles of autonomy and comprehension will be upheld.

Because clear and simple wording is a basic requirement for informed consent, the IRB/REC may need to confirm a different version of consent based on language relevant to the study participants’ inclusion criteria in some cases.

Parental consent

Two original items highlighted that there must be sufficient provisions for soliciting the assent of children [19, 52]. In other words, for research involving children, ample time and resources should be given to both the children and their parents to understand and reach joint consensus. Perhaps, it is an overstatement to say that children have equal portions of consensus in joint consensus. According to Hein, minors should adopt a dual consent approach from the age of 12 until they are given independent consent rights (child and parent) [53]. Based on this approach, even if a child's decision-making competence in the medical choice at hand is established, a dual consent approach will take into account developmental elements of children as well as the unique qualities of the parent–child dyad. The parental role is necessary to provide further safety by setting the stage for the child's competent decision-making and facilitating his or her long-term autonomy.

In this regard, the IRB/REC approval requires the study to verify that the study protocol is in tandem with local regulations pertaining to children. Therefore, the study team's compliance with local regulations on children should be described in the IRB/REC application. For instance, the research team could initially acquire parental consent over the phone.

Based on the research question formulated earlier in this review, using the context of research ethics review and oversight, the number of primary papers focusing on this context was limited. Therefore, it was decided to include more general research ethics criteria on electronic informed consent to identify the constructs. The ethical criteria developed in this study, however, still requires validation from the expert consensus through focus group discussion. Hence, our future work will be concentrated on developing eConsent checklists based on the criteria in this study by recruiting the expert participants amongst the IRB/REC members for validation. It is interesting to note that since the developed criteria is generic in nature, validation from the healthcare researchers may also be vitally important. This study recommends a two-pronged approach for the expert validation to work on in future with (i) IRB/REC members and (ii) healthcare researchers.

Conclusion

The use of electronic informed consent should not be used to replace human connection; rather, technology can be used to supplement it. Participants should still be able to ask researchers questions, and they may also be able to ask each other questions through social annotations. Lack of access to and knowledge with the technology, on the other hand, can pose additional barriers to consent. As technology improves, the number of participants may grow as they are no longer restricted by their geographic closeness to the research facility. However, until that time comes, participation may skew toward younger, more affluent people who already have access.

The current study adds significant value to the corpus of knowledge in research ethics by providing criteria to conduct and review the electronic informed consent for both researchers and IRB/REC, respectively, based on evidence-based data. The new synthesized criteria can be readily used as an initial guide by the IRB/REC members during a review process on electronic informed consent.

As a result, the practice of delivering electronic informed consent will have major ramifications in terms of the advantages being more participant centric. The autonomy and beneficence to research participants will be optimized through their understanding and the use of technology to minimize infection encounters during the pandemic, respectively. As more research adapts to the use of electronic media and makes the practice of electronic informed consent inevitable in the pandemic of COVID-19, it is envisaged that there will be a great deal of research protocols pertaining to electronic forms coming to the IRB/REC. The current electronic informed consent criteria is, therefore, can be considered as a pre-emptive measure to help the IRB/REC in managing the review process.

Supplementary Information

12910_2022_849_MOESM1_ESM.docx (55.8KB, docx)

Additional file 1. Standardized Charting Form.

12910_2022_849_MOESM2_ESM.docx (15.8KB, docx)

Additional file 2. Search strategy for the databases.

12910_2022_849_MOESM3_ESM.docx (144.5KB, docx)

Additional file 3. Data Collection Table.

Acknowledgements

The authors would like to express their appreciation to all MOHRE secretariats and graduates at University of Malaya, Malaysia. The programme was funded by the Fogarty International Center of the United States National Institutes of Health (Grant R25TW010891).

Abbreviations

eConsent

Electronic informed consent

IRB/REC

Institutional review board/research ethics committee

MeSH

Medical subject headings

PRISMA

Preferred reporting items for systematic review and meta-analyses

REDCap

Research electronic data capture

FHIR

Fast healthcare interoperability resources

CAPTCHA

Completely automated public turing test to tell computers and humans apart

STRIDE

Strengthening translational research in diverse enrolment

Author contributions

Author MYPMY carried out the data collection, analysis and wrote the manuscript draft. Author NCJ was involved in the formulation of study design, preparation of inclusion and exclusion criteria and revised the manuscript. Author TCH assisted in data analysis, interpretation and statistical analysis, and revised the manuscript. All authors read and approved the final version of the manuscript.

Funding

This work was supported by the Universiti Teknologi MARA, Cawangan Selangor (UCS) for the financial support via Dana UCS 600-UITMSEL (P.I 5/4) (37/2022).

Availability of data and materials

The datasets generated and analyzed during the current study are not publicly available due to the security of data but are available from the corresponding author on reasonable request.

Declarations

Ethics approval and consent to participate

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the Faculty of Medicine University of Malaya Research Review Board. The requirement for informed consent was waived by the University of Malaya Medical Center-Medical Research Ethics Committee (UMMC-MREC) because the study was a retrospective review of research protocols, and no human participants were involved. All methods were carried out in accordance with relevant guidelines and regulations.

Consent for publication

Not applicable.

Competing interests

The authors had no competing interests to declare in relation to this article.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Manti S, Licari A. How to obtain informed consent for research. Breathe (Sheff) 2018;14(2):145–152. doi: 10.1183/20734735.001918. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Mduluza T, et al. Study participants incentives, compensation and reimbursement in resource-constrained settings. BMC Med Ethics. 2013;14(1):S4. doi: 10.1186/1472-6939-14-S1-S4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Richardson V. Patient comprehension of informed consent. J Perioper Pract. 2013;23(1–2):26–30. doi: 10.1177/1750458913023001-204. [DOI] [PubMed] [Google Scholar]
  • 4.Kusec S, et al. Improving comprehension of informed consent. Patient Educ Couns. 2006;60(3):294–300. doi: 10.1016/j.pec.2005.10.009. [DOI] [PubMed] [Google Scholar]
  • 5.Pandiya A. Readability and comprehensibility of informed consent forms for clinical trials. Perspect Clin Res. 2010;1(3):98–100. [PMC free article] [PubMed] [Google Scholar]
  • 6.Farrell EH, et al. Systematic review and meta-analysis of audio-visual information aids for informed consent for invasive healthcare procedures in clinical practice. Patient Educ Couns. 2014;94(1):20–32. doi: 10.1016/j.pec.2013.08.019. [DOI] [PubMed] [Google Scholar]
  • 7.Herrera CD. Research ethics at the empirical side: research ethics: a psychological approach, edited by Barbara Stanley, Joan Sieber, and Gary Melton; illusions of reality: a history of deception in social psychology, by James Korn. Theor Med Bioeth. 1999;20(2):191–200. doi: 10.1023/A:1009983711120. [DOI] [PubMed] [Google Scholar]
  • 8.Department of Health, E., et al., The Belmont report. Ethical principles and guidelines for the protection of human subjects of research. J Am Coll Dent. 2014; 81(3): 4–13. [PubMed]
  • 9.Skelton E, et al. Electronic consenting for conducting research remotely: a review of current practice and key recommendations for using e-consenting. Int J Med Inform. 2020;143:104271. doi: 10.1016/j.ijmedinf.2020.104271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Rothwell E, et al. A randomized controlled trial of an electronic informed consent process. J Empir Res Human Res Ethics Int J. 2014;9(5):1–7. doi: 10.1177/1556264614552627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Jaton E, et al. The use of electronic consent for COVID-19 clinical trials: lessons for emergency care research during a pandemic and beyond. Acad Emerg Med. 2020;27(11):1183–1186. doi: 10.1111/acem.14141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Bharucha AE, et al. Increased utilization of virtual visits and electronic approaches in clinical research during the COVID-19 pandemic and thereafter. Mayo Clin Proc. 2021;96(9):2332–2341. doi: 10.1016/j.mayocp.2021.06.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Love SB, et al. Monitoring advances including consent: learning from COVID-19 trials and other trials running in UKCRC registered clinical trials units during the pandemic. Trials. 2021;22(1):279. doi: 10.1186/s13063-021-05225-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Trace S, Kolstoe SE. Measuring inconsistency in research ethics committee review. BMC Med Ethics. 2017;18(1):65. doi: 10.1186/s12910-017-0224-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Gesualdo F, et al. Digital tools in the informed consent process: a systematic review. BMC Med Ethics. 2021;22(1):18. doi: 10.1186/s12910-021-00585-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Arksey H, O'Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19–32. doi: 10.1080/1364557032000119616. [DOI] [Google Scholar]
  • 17.Tricco AC, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467–473. doi: 10.7326/M18-0850. [DOI] [PubMed] [Google Scholar]
  • 18.Peters MD, et al. Guidance for conducting systematic scoping reviews. Int J Evid Based Healthc. 2015;13(3):141–146. doi: 10.1097/XEB.0000000000000050. [DOI] [PubMed] [Google Scholar]
  • 19.Chen C, et al. Evaluation of a REDCap-based workflow for supporting federal guidance for electronic informed consent. AMIA Jt Summits Transl Sci Proc. 2019;2019:163–172. [PMC free article] [PubMed] [Google Scholar]
  • 20.Kane EI, 3rd. Gallo JJ. Perspectives of IRB chairs on the informed consent process. AJOB Empir Bioeth. 2017;8(2):137–143. doi: 10.1080/23294515.2016.1253628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Weber M, et al. A FHIR-based eConsent app for the digital hospital. Stud Health Technol Inform. 2020;270:3–7. doi: 10.3233/SHTI200111. [DOI] [PubMed] [Google Scholar]
  • 22.Asch DA, et al. Rethinking ethical oversight in the era of the learning health system. Healthcare. 2020;8(4):100462. doi: 10.1016/j.hjdsi.2020.100462. [DOI] [PubMed] [Google Scholar]
  • 23.Simon CM, Klein DW, Schartz HA. Traditional and electronic informed consent for biobanking: a survey of U.S. biobanks. Biopreserv Biobank. 2014;12(6):423–429. doi: 10.1089/bio.2014.0045. [DOI] [PubMed] [Google Scholar]
  • 24.Welch BM, et al. Teleconsent: a novel approach to obtain informed consent for research. Contemp Clin Trials Commun. 2016;3:74–79. doi: 10.1016/j.conctc.2016.03.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Balestra M, et al. Social annotation valence: the impact on online informed consent beliefs and behavior. J Med Internet Res. 2016;18(7):e197–e197. doi: 10.2196/jmir.5662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Thiel DB, et al. Testing an online, dynamic consent portal for large population biobank research. Public Health Genomics. 2015;18(1):26–39. doi: 10.1159/000366128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Blake DR, et al. Development and evaluation of a web-based assent for adolescents considering an HIV vaccine trial. AIDS Care. 2015;27(8):1005–1013. doi: 10.1080/09540121.2015.1024096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Hyeoneui K, et al. iCONCUR: informed consent for clinical data and bio-sample use for research. J Am Med Inform Assoc. 2017;24(2):380–387. doi: 10.1093/jamia/ocw115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Blake K, et al. Use of mobile devices and the internet for multimedia informed consent delivery and data entry in a pediatric asthma trial: study design and rationale. Contemp Clin Trials. 2015;42:105–118. doi: 10.1016/j.cct.2015.03.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Simon CM, et al. Perspectives on electronic informed consent from patients underrepresented in research in the united states: a focus group study. J Empir Res Hum Res Ethics. 2018;13(4):338–348. doi: 10.1177/1556264618773883. [DOI] [PubMed] [Google Scholar]
  • 31.Chen C, et al. replacing paper informed consent with electronic informed consent for research in academic medical centers: a scoping review. AMIA Jt Summits Transl Sci Proc. 2020;2020:80–88. [PMC free article] [PubMed] [Google Scholar]
  • 32.Balestra M, et al. The effect of exposure to social annotation on online informed consent beliefs and behaviour. In: Brewster S, Fitzpatrick G, editors. Proceedings of the 19th ACM conference on computer-supported cooperative work & social computing. Association for Computing Machinery: San Francisco, California; 2016. p. 900–912.
  • 33.Karunaratne AS, et al. Improving communication when seeking informed consent: a randomised controlled study of a computer-based method for providing information to prospective clinical trial participants. Med J Aust. 2010;192(7):388–392. doi: 10.5694/j.1326-5377.2010.tb03561.x. [DOI] [PubMed] [Google Scholar]
  • 34.Rowbotham MC, et al. Interactive informed consent: randomized comparison with paper consents. PLoS ONE. 2013;8(3):e58603. doi: 10.1371/journal.pone.0058603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Lindsley KA. Improving quality of the informed consent process: developing an easy-to-read, multimodal, patient-centered format in a real-world setting. Patient Educ Couns. 2019;102(5):944–951. doi: 10.1016/j.pec.2018.12.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Grady C, et al. Informed consent. N Engl J Med. 2017;376(9):856–867. doi: 10.1056/NEJMra1603773. [DOI] [PubMed] [Google Scholar]
  • 37.Hall EW, et al. Use of videos improves informed consent comprehension in web-based surveys among internet-using men who have sex with men: a randomized controlled trial. J Med Internet Res. 2017;19(3):1–1. doi: 10.2196/jmir.6710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Athanasopoulos E, Antonatos S. Enhanced CAPTCHAs: using animation to tell humans and computers apart. Berlin, Heidelberg: Springer, Berlin Heidelberg; 2006. [Google Scholar]
  • 39.Ahn LV, Blum M, Langford J. Telling humans and computers apart automatically. Commun ACM. 2004;47(2):56–60. doi: 10.1145/966389.966390. [DOI] [Google Scholar]
  • 40.Wood F, et al. Achieving online consent to participation in large-scale gene-environment studies: a tangible destination. J Med Ethics. 2011;37(8):487–492. doi: 10.1136/jme.2010.040352. [DOI] [PubMed] [Google Scholar]
  • 41.Chhin V, et al. Leveraging mobile technology to improve efficiency of the consent-to-treatment process. JCO Clin Cancer Inf. 2017;1:1–8. doi: 10.1200/CCI.17.00041. [DOI] [PubMed] [Google Scholar]
  • 42.Iwaya LH, et al. E-consent for data privacy: consent management for mobile health technologies in public health surveys and disease surveillance. Stud Health Technol Inform. 2019;264:1223–1227. doi: 10.3233/SHTI190421. [DOI] [PubMed] [Google Scholar]
  • 43.Lawrence CE, et al. A REDCap-based model for electronic consent (eConsent): moving toward a more personalized consent. J Clin Transl Sci. 2020;4(4):345–353. doi: 10.1017/cts.2020.30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Jimison HB, et al. The use of multimedia in the informed consent process. J Am Med Inform Assoc. 1998;5(3):245–256. doi: 10.1136/jamia.1998.0050245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Issa MM, et al. Informed versus uninformed consent for prostate surgery: the value of electronic consents. J Urol. 2006;176(2):694–699. doi: 10.1016/j.juro.2006.03.037. [DOI] [PubMed] [Google Scholar]
  • 46.Ramos SR. User-centered design, experience, and usability of an electronic consent user interface to facilitate informed decision-making in an HIV clinic. Comput Inform Nurs. 2017;35(11):556–564. doi: 10.1097/CIN.0000000000000356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Harle CA, et al. Patient preferences toward an interactive e-consent application for research using electronic health records. J Am Med Inform Assoc. 2018;25(3):360–368. doi: 10.1093/jamia/ocx145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Williams H, et al. Dynamic consent: a possible solution to improve patient confidence and trust in how electronic patient records are used in medical research. JMIR Med Inform. 2015;3(1):e3–e3. doi: 10.2196/medinform.3525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.De Sutter E, et al. Implementation of electronic informed consent in biomedical research and stakeholders’ perspectives: systematic review. J Med Internet Res. 2020;22(10):e19129. doi: 10.2196/19129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Brooks BS, et al. An electronic surgical order, undertaking patient education, and obtaining informed consent for regional analgesia before the day of surgery reduce block-related delays. Local Reg Anesth. 2016;9:59–64. doi: 10.2147/LRA.S115432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Frost CJ, et al. Electronic informed consent information for residual newborn specimen research: findings from focus groups with diverse populations. J Community Genet. 2021;12(1):199–203. doi: 10.1007/s12687-020-00496-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Chantler T, et al. Does electronic consent improve the logistics and uptake of HPV vaccination in adolescent girls? A mixed-methods theory informed evaluation of a pilot intervention. BMJ Open. 2020;10(11):e038963. doi: 10.1136/bmjopen-2020-038963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Hein IM, et al. Informed consent instead of assent is appropriate in children from the age of twelve: policy implications of new findings on children’s competence to consent to clinical research. BMC Med Ethics. 2015;16(1):76–76. doi: 10.1186/s12910-015-0067-z. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

12910_2022_849_MOESM1_ESM.docx (55.8KB, docx)

Additional file 1. Standardized Charting Form.

12910_2022_849_MOESM2_ESM.docx (15.8KB, docx)

Additional file 2. Search strategy for the databases.

12910_2022_849_MOESM3_ESM.docx (144.5KB, docx)

Additional file 3. Data Collection Table.

Data Availability Statement

The datasets generated and analyzed during the current study are not publicly available due to the security of data but are available from the corresponding author on reasonable request.


Articles from BMC Medical Ethics are provided here courtesy of BMC

RESOURCES